Acute Neuromuscular Disorder Management

Initial Assessment and Monitoring

The American College of Physicians recommends immediate hospital admission with ICU-level monitoring for suspected acute neuromuscular disorder, given the combination of progressive weakness, sensory loss, and significant weight loss 1, 2
Measuring respiratory function immediately, including negative inspiratory force (NIF) and vital capacity (VC), is crucial as respiratory failure can develop rapidly in neuromuscular disorders 3, 2
Evaluating for bulbar symptoms such as dysphagia, dysarthria, and facial weakness is essential to identify impending respiratory compromise 3, 2
Monitoring autonomic instability, including blood pressure fluctuations and heart rate abnormalities, can suggest Guillain-Barré syndrome 1
Ensuring ICU capability for immediate intubation and mechanical ventilation is necessary for patient care 4, 5

Checking creatine kinase (CK) and aldolase levels can help identify myositis or rhabdomyolysis, which can be life-threatening 2
Obtaining troponin and ECG is necessary to assess for myocardial involvement, which can occur with inflammatory myopathies and is potentially fatal 2
Conducting a complete metabolic panel to assess for electrolyte abnormalities and renal function is part of the diagnostic workup 2
Inflammatory markers (ESR, CRP) should be evaluated as they can be elevated in inflammatory myopathies 1

Clinical features strongly suggesting Guillain-Barré syndrome include progressive ascending weakness and global sensory loss, requiring immediate diagnostic workup and potential treatment with IVIG or plasmapheresis 1, 4
For myasthenia gravis, diagnostic testing includes acetylcholine receptor (AChR) and anti-MuSK antibodies, electrodiagnostic studies, and bedside Tensilon test or ice pack test 1, 3
Treatment for myasthenia gravis involves pyridostigmine, prednisone, and avoiding medications that worsen MG, such as β-blockers and fluoroquinolones 3, 4

Quetiapine should not be abruptly discontinued due to the risk of withdrawal symptoms and psychosis recurrence 5
Quetiapine does not worsen myasthenia gravis, as it is not listed among contraindicated medications 4, 3

Neurologist involvement is mandatory for all grades of suspected neuromuscular weakness given the potential for rapid deterioration 4, 5, 2

Overlooking myocardial involvement can miss life-threatening cardiac complications, emphasizing the need to check troponin and ECG 2
Delaying respiratory monitoring can lead to sudden deterioration in neuromuscular disease patients 3
Using non-invasive ventilation in the presence of bulbar dysfunction can increase the likelihood of NIV failure 3
Waiting for complete diagnostic workup before initiating treatment can delay necessary interventions, such as intubation in cases of respiratory compromise 3